Improvements in diagnosis and risk assessment of primary and secondary antiphospholipid syndrome

Research output: Contribution to journalArticlepeer-review

Abstract

Classification criteria for antiphospholipid syndrome have not been updated since the revised Sapporo classification criteria were published in 2006. These criteria have limitations in that they omit nonclassical manifestations (hematologic and neurologic), include anticardiolipin and anti-β2-glycoprotein I immunoglobulin (Ig)M isotypes, and do not separately consider primary (no autoimmune disease) or secondary (usually systemic lupus erythematosus) disease. Recent findings in antiphospholipid antibody include fluctuation of antiphospholipid antibodies, recognition that IgA isotypes do confer risk, identification of the role of complementopathy in catastrophic antiphospholipid syndrome, and elucidation of the role of thrombosis risk equations.

Original languageEnglish (US)
Pages (from-to)415-420
Number of pages6
JournalHematology (United States)
Volume2019
Issue number1
DOIs
StatePublished - Dec 6 2019

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Improvements in diagnosis and risk assessment of primary and secondary antiphospholipid syndrome'. Together they form a unique fingerprint.

Cite this